from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3277/-

LFCtreatmentdescriptionclass of inhibitor

-0.951

Amikacinug/mL Amikacintranslation

-0.000

Cap5-10ug/mL Capreomycintranslation

0.133

Rox10-50 ug/mL Roxithromycintranslation

0.897

SM2-5 ug/mL Streptomycintranslation

-2.221

Tet5-10 ug/mL Tetracyclinetranslation

0.841

Rif0.2-5ug/mL Rifampicintranscription

-0.164

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.349

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.152

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.169

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.671

Clofazimine10-13 ug/mL Clofaziminerespiration

0.237

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.807

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.413

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.380

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.103

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.238

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.109

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.862

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.109

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.845

KCN5-20 ug/mL Potassium cyaniderespiration

-0.359

NaN30.2-2 mM Sodium aziderespiration

1.091

Nigericin50 uM Nigericinrespiration

-1.052

TRC10-150 ug/mL Triclosanrespiration

-0.944

TRZ10-25 ug/mL Thioridazinerespiration

-0.723

Valinomycin0.5-10 uM Valinomycinrespiration

0.408

ZnSO42 mM ZnSO4respiration

0.849

menadione6-10 ug/mL Menadionerespiration

0.140

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.470

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.163

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.210

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.138

NRP_1Non-replicating persistence stage 1dosRassociated

0.629

Amp0.2mg/mL AmpicillincellWall

0.408

Cephalexin20-100 ug/mL CephalexincellWall

0.737

Cerulenin0.32-5 ug/mL CerulenincellWall

0.486

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.171

EMB10-20 ug/mL EthambutolcellWall

0.907

Eta12-40 ug/mL EthionamidecellWall

1.877

INH0.2-0.4 ug/mL IsoniazidcellWall

0.691

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.060

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.050

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.141

BZA0.12 mg/mL BenzamidearomaticAmides

0.070

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.561

H2O24 mM hydrogen peroxideDNAdamaging

0.196

Levo10 ug/mL LevofloxacinDNAdamaging

-0.042

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.008

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.012

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.254

UVUV-irradiationDNAdamaging

-0.285

ARP41-4 ug/mL Antitubercular compound ARP4?

0.265

Antimycin12.5-50 ug/mL Antimycin A?

0.220

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.943

PA_110-50 ug/mL Antitubercular compound PA-1?

0.648

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.075

PA8240.2-2 ug/mL PA-824?

-0.326

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.447

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.660

Verapamil50 uM Verapamil?

0.017

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.416

methoxatin10-20 ug/mL Methoxatin?